Digoxin and Oxymetazoline interaction
Digoxin and Oxymetazoline: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Digoxin label · effective 2025-04-10
Sympathomimetics Epinephrine Can increase the risk of cardiac arrhythmias.
From the Oxymetazoline (UPNEEQ) label · effective 2026-07-23
Caution in using drugs such as beta-blockers, anti-hypertensives, and/or cardiac glycosides is advised.
Anti-hypertensives/Cardiac Glycosides Alpha-adrenergic agonists, as a class, may impact blood pressure.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.